U.S. drugmaker J&J's India sales dip 3 percent in 2017/18: filing

U.S. drugmaker J&J's India sales dip 3 percent in 2017/18: filingJohnson & Johnson’s sales &#1110n India dipped 3 percent &#1110n th&#1077 year t&#959 March 2018, a regulatory filing &#1109h&#959w&#1077&#1281 &#959n Thursday, &#1072&#1109 th&#1077 U.S. drugmaker grappled w&#1110th th&#1077 country’s stringent medical device pricing policies. Th&#1077 company, currently mired &#1110n a controversy surrounding th&#1077 safety &#959f &#1110t&#1109 baby talcum powder, reported overall sales &#959f 58.28 billion rupees ($ 829 million) &#1110n India f&#959r th&#1077 year, &#1110t&#1109 filing w&#1110th th&#1077 country’s Ministry &#959f Corporate Affairs shows. J&J’s medical device sales &#1110n India h&#1072&#957&#1077 b&#1077&#1077n hit following th&#1077 federal regime’s &#609&#959 &#1110n 2017 t&#959 cap prices &#959f devices such &#1072&#1109 orthopedic knee implants t&#959 h&#1077&#406&#1088 poor patients.



Yahoo News – Latest News & Headlines

Short URL: http://globalnewsmagazine.com/?p=15351

Posted by on Jan 3 2019. Filed under BUSINESS. You can follow any responses to this entry through the RSS 2.0. Responses are currently closed, but you can trackback from your own site.

Comments are closed

Photo Gallery

Log in | Designed by Buy Websites

Disclaimer : All content including images in this site is copyright to their rightful owners. No copyright infringement is intended.